Features of adaptive plasma cell immune response at dofferent stages of polypous rhinosinusitis
- Authors: Lengina M.A.1, Korkmazov A.M.1, Kazachkov E.L.1, Medvedeva Y.A.1
-
Affiliations:
- South Ural State Medical University
- Issue: Vol 28, No 3 (2025)
- Pages: 625-630
- Section: SHORT COMMUNICATIONS
- URL: https://journals.rcsi.science/1028-7221/article/view/319911
- DOI: https://doi.org/10.46235/1028-7221-17179-FOA
- ID: 319911
Cite item
Full Text
Abstract
Identification of phenotypes/genotypes in development of polypous rhinosinusitis enabled us to understand some mechanisms of remodeling mucous membranes in nasal cavity and paranasal sinuses, and choose optimal and effective treatment strategies. At the same time, the current studies show a continuing trend towards higher incidence of polypous rhinosinusitis, with frequent relapses accompanied by a significant decrease in quality of life. In this regard, the issues of searching markers of endotyping polypous rhinosinusitis remain relevant, thus enabling proper treatment to the patient at an early stage and ensuring clinical prognosis of the disease. Our aim was to analyze the relative density of immunocompetent lymphocytic cells with morphometric confirmation in patients with polypous rhinosinusitis with immune T2-inflammation. The study was conducted in a group of 22 patients with a verified diagnosis of polypous rhinosinusitis who were hospitalized for elective surgery. All patients were divided into the main group, the T2 polypous rhinosinusitis endotypem, and a comparison group which included patients with non-T2 polypous rhinosinusitis endotype. Anamnestic, clinical and laboratory data and morphometric criteria of both groups have been analyzed. In the main group of patients, there was a trend for distinct increase in absolute number of blood eosinophils (from 320 to 1512 cells/mL). The analysis of anamnestic data revealed increased frequency of repeated surgery (21.4%) in the patients from main group as compared to the control group (12.5%). A long disease history (29 years), and long relapse period (up to 27.5 years) was noted in the control group. In the main group, with shorter course of polypous rhinosinusitis (18.2 years), the duration of relapse was more than 4 times shorter compared to the time period of relapses in control group, being only 6 years. Morphometric analysis of intraoperatively taken polyp tissue has shown that the relative density of plasmocytes in the inflammatory polyp stroma in the main group of patients was higher than in the control group and reached 0.06 and 0.04 cells per 1 mm2, respectively. The search for pathogenetic markers of morphometric features and immunological aspects of specific immune response in patients with polypous rhinosinusitis will make it possible to administer effective treatment to the patient and predict the outcome of the disease.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
M. A. Lengina
South Ural State Medical University
Email: korkmazov74@gmail.com
PhD (Medicine), Associate Professor, Department of Otorhinolaryngology
Russian Federation, ChelyabinskA. M. Korkmazov
South Ural State Medical University
Author for correspondence.
Email: Korkmazov09@gmail.com
PhD (Medicine),Associate Professor, Department of Otorhinolaryngology
Russian Federation, ChelyabinskE. L. Kazachkov
South Ural State Medical University
Email: Korkmazov09@gmail.com
PhD, MD (Medicine), Professor, Head, Department of Pathological Anatomy and Forensic Medicine
Russian Federation, ChelyabinskYu. A. Medvedeva
South Ural State Medical University
Email: Korkmazov09@gmail.com
PhD (Medicine), Associate Professor, Department of Pathological Anatomy and Forensic Medicine
Russian Federation, ChelyabinskReferences
- Коркмазов М.Ю., Корнова Н.В., Ленгина М.А., Смирнов А.А., Коркмазов А.М., Дубинец И.Д. Эффективная антибактериальная терапия внебольничной оториноларингологической респираторной инфекции (клиническое описание) // Медицинский совет, 2022. № 20. С. 73-81. [Korkmazov M.Yu., Kornova N.V., Lengina M.A., Smirnov A.A., Korkmazov A.M., Dubinets I.D. Effective antibiotic therapy for community-acquired otorhinolaryngological respiratory infection (clinical description). Meditsinskiy sovet = Medical Council, 2022, no. 20, pp. 73-81. (In Russ.)]
- Коркмазов М.Ю., Ленгина М.А., Коркмазов А.М., Кравченко А.Ю. Влияние постковидного синдрома на качество жизни пациентов с аллергическим ринитом и эозинофильным фенотипом хронического полипозного риносинусита // Российский медицинский журнал, 2023. Т. 29, № 4. C. 277-290. [Korkmazov M. Yu., Lengina M.A., Korkmazov A.M., Kravchenko A.Y. Effect of post-COVID syndrome on the quality of life of patients with allergic rhinitis and eosinophilic phenotype of chronic polyposis rhinosinusitis. Rossiiskii meditsinskii zhurnal = Medical Journal of the Russian Federation, 2023, Vol. 29, no. 4, pp. 277-290. (In Russ.)]
- Коркмазов М.Ю., Зырянова К.С., Белошангин А.С. Оценка клинической эффективности фитотерапевтического лекарственного препарата в лечении и профилактике рецидивов острых риносинуситов у детей г. Челябинска // Медицинский совет, 2016. № 7. С. 90-93. [Korkmazov M.Yu., Zyryanova K.S., Beloshangin A.S. Evaluation of the clinical efficacy of a phytotherapeutic drug in the treatment and prevention of recurring acute rhinosinusitis in children of Chelyabinsk. Meditsinskiy sovet = Medical Council, 2016, no. 7, pp. 90-93. (In Russ.)]
- Коркмазов М.Ю., Ястремский А.П., Корнова Н.В., Ленгина М.А., Коркмазов А.М. Лечебно-диагностические подходы в терапии хронического тонзиллита // Медицинский совет, 2022. № 20. С. 90-99. [Korkmazov M.Yu., Yastremsky A.P., Kornova N.V., Lengina M.A., Korkmazov A.M. Therapeutic and diagnostic approaches in the treatment of chronic tonsillitis. Meditsinskiy sovet = Medical Council, 2022, no. 20, pp. 90-99. (In Russ.)]
- Коркмазов М.Ю., Казачков Е.Л., Ленгина М.А., Дубинец И.Д., Коркмазов А.М. Причинно-следственные факторы развития полипозного риносинусита // Российская ринология, 2023. Т. 31, № 2. С. 124-130. [Korkmazov M.Yu., Kazachkov E.L, Lengina M.A., Dubinets I.D., Korkmazov A.M. Cause-effect factors of rhinosinusitis poliposa development. Rossiyskaya rinologiya = Russian Rhinology, 2023, Vol. 31, no. 2, pp. 124-130. (In Russ.)]
- Коркмазов М.Ю., Ангелович М.С., Ленгина М.А., Белоусов С.Ю. Клинический случай ангиосаркомы решетчатого лабиринта и лобной пазухи, вопросы морфологической верификации диагноза // Вестник оториноларингологии, 2022. Т. 87, № 4. С. 102-106. [Korkmazov M.Yu., Angelovich M.S., Lengina M.A., Belousov S.Y. Clinical case of angiosarcoma of the latticed labyrinth and frontal sinus, issues of morphological verification of diagnosis. Vestnik otorinolaringologii = Bulletin of Otorhinolaryngology, 2022, Vol. 87, no. 4, pp. 102-106. (In Russ.)]
- Лазарева А.М., Смирнова О.В. Иммунологические особенности различных фенотипов хронического риносинусита // Медицинская иммунология, 2025. Т. 27, № 2. С. 275-286. [Lazareva, A.M., Smirnova O.V. Immunological features of various phenotypes of chronic rhinosinusitis. Meditsinskaya immunologiya = Medical Immunology (Russia), 2025, Vol. 27, no. 2. pp. 275-286. (In Russ.)] doi: 10.15789/1563-0625-IFO-3026.
- Полипозный риносинусит: клинические рекомендации. М., 2019. 34 с. [Электронный ресурс]. Режим доступа: https://www.vodkb.ru/wp-content/uploads/pages/documents/klin-recomend/Polipoznyj-rinosinusit19.pdf. [Polypous rhinosinusitis: сlinical recommendations]. Moscow, 2019. 34 p. [Electronic resource]. Available at: https://www.vodkb.ru/wp-content/uploads/pages/documents/klin-recomend/Polipoznyj-rinosinusit19.pdf.
- Полипозный риносинусит: клинические рекомендации. М., 2024. 37 с. Режим доступа: https://cr.minzdrav.gov.ru/view-cr/890_1. [Polypous rhinosinusitis: clinical recommendations]. Moscow, 2024. 37 p. Available at: https://cr.minzdrav.gov.ru/view-cr/890_1.
- Fokkens W.J., Lund V.J., Hopkins C., Hellings P.W., Kern R., Reitsma S., Toppila-Salmi S., Bernal-Sprekelsen M., Mullol J. Executive summary of EPOS 2020 including integrated care pathways. Rhinology, 2020, Vol. 58, no. 2, pp. 82-111.
- Halderman A., Lane AP. Genetic and Immune Dysregulation in Chronic Rhinosinusitis. Otolaryngol. Clin. North Am., 2017, Vol. 50, no. 1, pp. 13-28.
- Ho J., Bailey M., Zaunders J., Mrad N., Sacks R., Sewell W., Harvey RJ.Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia. Clin. Exp. Allergy, 2015, Vol. 45, no. 2. pp. 394-403.
- Lund V.J., Kennedy D.W. Quantification for staging sinusitis. The Staging and Therapy Group. Ann. Otol. Rhinol. Laryngol. Suppl., 1995, Vol. 167, pp. 17-21
- Lund V, Mackay I.S. Staging in chronic rhinosinusitis. Rhinology, 1993, Vol. 31, no. 4, pp. 183-184.
- Pan L., Liu Z. Classification of chronic rhinosinusitis with nasal polyps based on eosinophilic inflammation. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2019, Vol. 54, no. 3, pp. 222-226. (In Chinese)
Supplementary files
